Literature DB >> 27424042

Predictors of 5-year local, regional, and distant recurrent events in a population-based cohort of breast cancer patients.

Filgen Fung1, Sylvie D Cornacchi1, Thuva Vanniyasingam2, Dyda Dao1, Lehana Thabane2, Marko Simunovic3, Nicole Hodgson3, Mary Ann O'Brien4, Susan Reid3, Barbara Heller3, Peter J Lovrics5.   

Abstract

BACKGROUND: The study purpose was to identify tumor and surgeon predictors of local recurrence (LR), regional recurrence (RR), and distant metastasis (DM) after breast cancer (BC) surgery in a population-based cohort.
METHODS: Consecutive BC surgical cases from 12 hospitals in South Central Ontario between May 2006 and October 2006 were included. Data collected on chart review included patient and tumor factors, surgery type, adjuvant treatment, surgeon specialty, surgeon case volume, and practice type. Univariate and multivariable survival analyses were performed.
RESULTS: Median follow-up was 5.5 years for 402 patients (97% of sample). LR, RR, and DM occurred in 18 (4.5%), 10 (2.5%), and 47 (12%) patients, respectively. Significant predictors of BC recurrence (LR or RR or DM) were tumor size and grade, nodal status, and lymphovascular invasion on multivariable analysis.
CONCLUSION: Tumor factors such as size, grade, lymphovascular invasion, and nodal status predicted BC recurrence, while practice type, surgeon specialty, and case volume did not.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer-specific mortality; Breast conserving surgery; Mastectomy; Surgeon specialty; Surgeon volume

Mesh:

Year:  2016        PMID: 27424042     DOI: 10.1016/j.amjsurg.2016.03.016

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  [MiR-4443 promotes migration and invasion of breast cancer cells by inhibiting PEBP1 expression].

Authors:  Jinyan Wang; Jinqiu Wang; Quan Gu; Yan Yang; Yajun Ma; Jing Zhu; Quanan Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-12-30

2.  miR-200b inhibits proliferation and metastasis of breast cancer by targeting fucosyltransferase IV and α1,3-fucosylated glycans.

Authors:  Q Zheng; X Cui; D Zhang; Y Yang; X Yan; M Liu; B Niang; F Aziz; S Liu; Q Yan; J Liu
Journal:  Oncogenesis       Date:  2017-07-10       Impact factor: 7.485

3.  Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway.

Authors:  Yifan Wang; Ruocen Liao; Xingyu Chen; Xuhua Ying; Guanping Chen; Mingqian Li; Chenfang Dong
Journal:  Cell Death Dis       Date:  2020-07-09       Impact factor: 8.469

4.  The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer.

Authors:  Xinfeng Zhang; Dandan Wang; Zhuangkai Liu; Zheng Wang; Qiang Li; Hong Xu; Bin Zhang; Ting Liu; Feng Jin
Journal:  Quant Imaging Med Surg       Date:  2020-01

5.  Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.

Authors:  Sin-Hua Moi; Yi-Chen Lee; Li-Yeh Chuang; Shyng-Shiou F Yuan; Fu Ou-Yang; Ming-Feng Hou; Cheng-Hong Yang; Hsueh-Wei Chang
Journal:  Cancer Cell Int       Date:  2018-02-09       Impact factor: 5.722

Review 6.  Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers.

Authors:  Wenyong Tan; Ming Yang; Hongli Yang; Fangbin Zhou; Weixi Shen
Journal:  Cancer Manag Res       Date:  2018-10-09       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.